How to buy Probiotec shares | A$1.795

Probiotec Limited is a drug manufacturers—specialty & generic business based in Australia. Probiotec shares (PBP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $1.795 – an increase of 5.59% over the previous week. Probiotec has a trailing 12-month revenue of around $107.2 million.

How to buy shares in Probiotec

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Probiotec . Find the share by name or ticker symbol: PBP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Probiotec reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $1.795, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Probiotec . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Probiotec 's share price?

Since the stock market crash in March caused by coronavirus, Probiotec 's share price has had significant negative movement.

Its last market close was $1.795, which is 23.62% down on its pre-crash value of $2.35 and 15.81% up on the lowest point reached during the March crash when the shares fell as low as $1.55.

If you had bought $1,000 worth of Probiotec shares at the start of February 2020, those shares would have been worth $781.83 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $815.92.

Probiotec share price

Use our graph to track the performance of PBP stocks over time.

Probiotec shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$1.795
52-week range	AUDA$1.55 - AUDA$2.48
50-day moving average	AUDA$1.7922
200-day moving average	AUDA$1.9057
Target price	N/A
PE ratio	18.6006
Dividend yield	AUDA$0.04 (2.52%)
Earnings per share (TTM)	AUDA$0.05

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Probiotec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Probiotec Limited by TradingView

Probiotec price performance over time

Historical closes compared with the close of A$1.795 on 2020-10-22

1 week (2020-10-15)	3.76%
1 month (2020-09-25)	0.84%
3 months (2020-07-24)	-9.34%
6 months (2020-04-24)	-4.01%

1 year (2019-10-25)	-10.70%
2 years (2018-10-25)	31.02%
3 years (2017-10-25)	184.92%
5 years (2015-10-23)	469.84%

Is Probiotec under- or over-valued?

Valuing Probiotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Probiotec 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Probiotec 's P/E ratio

Probiotec 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Probiotec shares trade at around 19x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Probiotec 's EBITDA

Probiotec 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million.

The EBITDA is a measure of a Probiotec 's overall financial performance and is widely used to measure a its profitability.

Probiotec financials

Revenue TTM	$107.2 million
Operating margin TTM	10.1%
Gross profit TTM	$31.8 million
Return on assets TTM	5.63%
Return on equity TTM	11.68%
Profit margin	3.27%
Book value	0.809
Market capitalisation	$134.6 million

TTM: trailing 12 months

Probiotec share dividends

Dividend payout ratio: 44.44% of net profits

Recently Probiotec has paid out, on average, around 44.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Probiotec shareholders could enjoy a 2.52% return on their shares, in the form of dividend payments. In Probiotec 's case, that would currently equate to about A$0.04 per share.

While Probiotec 's payout ratio might seem fairly standard, it's worth remembering that Probiotec may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 21 October 2020 (the "ex-dividend date").

Probiotec share price volatility

Over the last 12 months, Probiotec 's shares have ranged in value from as little as $1.55 up to $2.48. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Probiotec 's is 0.2863. This would suggest that Probiotec 's shares are less volatile than average (for this exchange).

Probiotec overview

Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

Frequently asked questions

• What percentage of Probiotec is owned by insiders or institutions?

  Currently 44.706% of Probiotec shares are held by insiders and 7.752% by institutions.

• When does the fiscal year end for Probiotec ?

  Probiotec 's fiscal year ends in June.

• Where is Probiotec based?

  Probiotec 's address is: 83 Cherry Lane, Laverton North, VIC, Australia, 3026

• What is Probiotec 's ISIN number?

  Probiotec 's international securities identification number is: AU000000PBP7